Aravive, Inc. Common Stock
ARAV
ARAV was delisted on the 26th of January, 2024.
49 hedge funds and large institutions have $35.2M invested in Aravive, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 18 reducing their positions, and 19 closing their positions.
27% more call options, than puts
Call options by funds: $1.05M | Put options by funds: $826K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 18
17% less funds holding
Funds holding: 59 → 49 (-10)
18% less capital invested
Capital invested by funds: $42.7M → $35.2M (-$7.58M)
53% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$836K |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$680K |
| 3 |
Renaissance Technologies
New York
|
+$335K |
| 4 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
+$297K |
| 5 |
E
Ergoteles
New York
|
+$294K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$3.31M |
| 2 |
State Street
Boston,
Massachusetts
|
-$922K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$562K |
| 4 |
Two Sigma Investments
New York
|
-$347K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$328K |
ARAV Hedge Fund Activity: Q2 2021 in Review
49 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Aravive, Inc. Common Stock (ARAV) for Q2 2021, worth a combined $35.2M — down 18% from $42.7M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of ARAV and 9 opened new positions — a net loss of 10 holders — while 18 trimmed existing stakes and 16 added.
The largest buyer was Morgan Stanley, adding an estimated $836K. The largest seller was BlackRock, cutting an estimated $3.31M.
- 49 institutional investors held Aravive, Inc. Common Stock (ARAV) as of Q2 2021, down from 59 in Q1 2021.
- Funds reported $35.2M of Aravive, Inc. Common Stock stock for Q2 2021, down 18% quarter-over-quarter.
- 9 funds opened new Aravive, Inc. Common Stock positions in Q2 2021 and 19 closed out, a net change of -10 holders.
- The largest Aravive, Inc. Common Stock buyer in Q2 2021 was Morgan Stanley, an estimated $836K added.
- The largest Aravive, Inc. Common Stock seller in Q2 2021 was BlackRock, an estimated $3.31M sold.
Based on aggregated 13F filings for Q2 2021.